Cite
HARVARD Citation
Lipplaa, A. et al. (2018). 25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial. British journal of cancer. 119 (7), pp. 793-800. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lipplaa, A. et al. (2018). 25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial. British journal of cancer. 119 (7), pp. 793-800. [Online].